Orphan vs. non-orphan pipeline sales forecast worldwide 2022-2028

Published by
Matej Mikulic,
Jun 19, 2023
This statistic shows the forecasted pipeline sales for orphan and non-orphan drugs worldwide from 2022 to 2028. For 2028, the forecasted pipeline sales for orphan drugs is around 76 billion U.S. dollars whereas for non-orphan drugs sales is forecasted to be 198 billion U.S. dollars.

Pipeline sales forecast for orphan and non-orphan drugs worldwide from 2022 to 2028 (in billion U.S. dollars)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2023

Region

Worldwide

Survey time period

as of February 2023

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Orphan drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Orphan drugs

Rare diseases

4

Market overview

5

Companies

4

Products

6

Research and development

6

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Orphan drugsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDiseases
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu